Annual Drug Patent Expirations for ABSORICA
Absorica is a drug marketed by Sun Pharm Inds Inc and Sun Pharm and is included in two NDAs. It is available from one supplier. There are seven patents protecting this drug and five Paragraph IV challenges.
Drug patent litigation for ABSORICA.
This drug has eleven patent family members in nine countries.
The generic ingredient in ABSORICA is isotretinoin. One supplier is listed for this compound. Additional details are available on the isotretinoin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com